Oncología Médica Traslacional y Terapia Individualizada del Cáncer

Conde, E; Hernandez, S; Carrillo, JLR; Martinez, R; Alonso, M; Curto, D; Jimenez, B; Caminoa, A; Benito, A; Garrido, P; Clave, S; Arriola, E; Esteban-Rodriguez, I; De Castro, J; Sansano, I; Felip, E; Rojo, F; Dómine, M; Abdulkader, I; Garcia-Gonzalez, J; Teixido, C; Reguart, N; Compañ, D; Insa, A; Mancheño, N; Palanca, S; Juan-Vidal, O; Baixeras, N; Nadal, E; Cebollero, M; Calles, A; Martin, P; Salas, C; Provencio, M; Aranda, I; Massuti, B; Lopez-Vilaro, L; Majem, M; Paz-Ares, L; Lopez-Rios, F.

RET Fusion Testing in Patients With NSCLC: The RETING Study

Jto Clinical And Research Reports. 2024; 5(4): Nº de citas: 3 [doi:10.1016/j.jtocrr.2024.100653]

Kim, DW; Cho, BC; Pachipala, K; Kim, SW; Wang, CL; Chang, GC; Ahn, MJ; Alvarez, R; Chiu, CH; Trigo, J; Estival, A; Karam, SD; O'Brien, C; Gowda, H; Jiang, HY; Bauman, JE.

Durvalumab in combination with chemoradiotherapy for patients with unresectable stage III non-small-cell lung cancer: Results from the phase 1 CLOVER study

LUNG CANCER. 2024; 190: Nº de citas: 5 [doi:10.1016/j.lungcan.2024.107530]

Caraballo, IG; Lozano, RM; Rodríguez, RJ; Alsar, JS; Morán, LO; Jiménez, MM; Martín, AJM.

Chronological pattern of venous thromboembolism (VTE) occurrence impacts in survival of pancreatic ductal adenocarcinoma (PDAC)

CLINICAL & TRANSLATIONAL ONCOLOGY. 2024; 26(9): 2116-2125 Nº de citas: 1 [doi:10.1007/s12094-024-03467-8]

Martinez-Jañez, N; Ezquerra, MB; Sanchez, LMM; Carrasco, FH; Torres, AA; Morales, S; Ortega, PT; Gil, VLO; Sampedro, T; Conejero, RA; Calvo-Martinez, L; Galve-Calvo, E; López, R; de la Pena, FA; Lopez-Tarruella, S; de Araguiz, BAHF; Ruiz, LB; Cardenas, TM; Chacon, JI; Antón, FM.

First-line therapy with palbociclib in patients with advanced HR⁺/HER2^- breast cancer: The real-life study PALBOSPAIN

BREAST CANCER RESEARCH AND TREATMENT. 2024; 206(1): 57-65 Nº de citas: 5 [doi:10.1007/s10549-024-07287-w]

Rueda, AG; Taus, A; Alvarez, RA; Bernabé-Caro, R; Chara, L; López-Brea, M; Vilà, L; González, MAS; Aldagalán, ADD; Herrera, BE; Castro, RL; Cabellos, RA; Doménech, M; Falagan, S; Vega, AM; Aguado, C; Barba, A; Ureña, MTD; Isla, D; Hernández, LB; Pérez, JLF; Juan-Vidal, O; Massuti, B; Mielgo-Rubio, X; Ortega, AL; Catot, S; Dómine, M; Escoín-Pérez, C; Navalón, FG; Gil-Bazo, I; Muñoz, S; Rodríguez-Abreu, D; Roldán, RMV; Curbera, GA; León-Mateos, L; Padilla, A; Lario, AP; Sánchez-Torres, JM; Garrido, P.

The S-REAL study: Spanish real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy

CLINICAL & TRANSLATIONAL ONCOLOGY. 2024; 26(9): 2205-2216 Nº de citas: 7 [doi:10.1007/s12094-024-03404-9]

Slamon, DJ; Diéras, V; Rugo, HS; Harbeck, N; Im, SA; Gelmon, KA; Lipatov, ON; Walshe, JM; Martin, M; Chavez-MacGregor, M; Bananis, E; Gauthier, E; Lu, DR; Kim, S; Finn, RS.

Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer

JOURNAL OF CLINICAL ONCOLOGY. 2024; 42(9): Nº de citas: 77 [doi:10.1200/JCO.23.00137]

Rastogi, P; O'Shaughnessy, J; Martin, M; Boyle, F; Cortes, J; Rugo, HS; Goetz, MP; Hamilton, EP; Huang, CS; Senkus, E; Tryakin, A; Cicin, I; Testa, L; Neven, P; Huober, J; Shao, ZM; Wei, R; André, V; Munoz, M; San Antonio, B; Shahir, A; Harbeck, N; Johnston, S.

Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes

JOURNAL OF CLINICAL ONCOLOGY. 2024; 42(9): Nº de citas: 97 [doi:10.1200/JCO.23.01994]

Villacampa, G; Pascual, T; Braso-Maristany, F; Pare, L; Martinez-Saez, O; Cortes, J; Ciruelos, E; Martin, M; Conte, P; Carey, LA; Fernandez, A; Harbeck, N; Marin-Aguilera, M; Vivancos, A; Curigliano, G; Villagrasa, P; Parker, JS; Perou, CM; Prat, A; Tolaney, SM.

Prognostic value of HER2DX in early-stage HER2-positive breast cancer: a comprehensive analysis of 757 patients in the Sweden Cancerome Analysis Network d Breast dataset (SCAN-B)

Esmo Open. 2024; 9(3): [doi:10.1016/j.esmoop.2024.102388]

Juric, D; Barve, M; Vaishampayan, U; Roda, D; Calvo, A; Janez, NM; Trigo, J; Greystoke, A; Harvey, RD; Olszanski, AJ; Opyrchal, M; Spira, A; Thistlethwaite, F; Jiménez, B; Sappal, JH; Kannan, K; Riley, J; Li, CRY; Li, C; Gregory, RC; Miao, HRY; Wang, SN.

A phase Ib study evaluating the recommended phase II dose, safety, tolerability, and efficacy of mivavotinib in combination with nivolumab in advanced solid tumors

Cancer Medicine. 2024; 13(5): [doi:10.1002/cam4.6776]

Tolaney, SM; Guarneri, V; Seo, JH; Cruz, J; Abreu, MH; Takahashi, M; Barrios, C; McIntyre, K; Wei, R; Munoz, M; San Antonio, B; Liepa, AM; Martin, M; Johnston, SRD; Kellokumpu-Lehtinen, PL; Harbeck, N.

Long-term patient-reported outcomes from monarchE: Abemaciclib plus endocrine therapy as adjuvant therapy for HR+, HER2-, node-positive, high-risk, early breast cancer

EUROPEAN JOURNAL OF CANCER. 2024; 199: [doi:10.1016/j.ejca.2024.113555]

García-Alfonso, P; Vera, R; Aranda, E; Elez, E; Rivera, F.

Delphi consensus for the third-line treatment of metastatic colorectal cancer

CLINICAL & TRANSLATIONAL ONCOLOGY. 2024; 26(6): 1429-1437 [doi:10.1007/s12094-023-03369-1]

Galsky, MD; Guan, XN; Rishipathak, D; Rapaport, AS; Shehata, HM; Banchereau, R; Yuen, K; Varfolomeev, E; Hu, RZ; Han, CJ; Li, HC; Liang, YX; Vucic, D; Wang, L; Zhu, J; Yu, HC; Herbst, RH; Hajaj, E; Kiner, E; Bamias, A; De Santis, M; Davis, ID; Arranz, JA; Kikuchi, E; Bernhard, S; Williams, P; Lee, C; Mellman, I; Sanjabi, S; Johnston, R; Black, PC; Grande, E; Mariathasan, S.

Immunomodulatory effects and improved outcomes with cisplatin- versus carboplatin-based chemotherapy plus atezolizumab in urothelial cancer

CELL REPORTS MEDICINE. 2024; 5(2): Nº de citas: 34 [doi:10.1016/j.xcrm.2024.101393]

Fernandez-Martinez, NF; Rodriguez-Barranco, M; Huerta, JM; Gil, F; Olmedo, P; Molina-Montes, E; Guevara, M; Zamora-Ros, R; Jimenez-Zabala, A; Colorado-Yohar, SM; Ardanaz, E; Bonet, C; Amiano, P; Chirlaque, MD; Perez-Gomez, B; Jimenez-Moleon, JJ; Martin-Jimenez, M; de Santiago, E; Sanchez, MJ.

Breast cancer risk for the joint exposure to metals and metalloids in women: Results from the EPIC-Spain cohort

SCIENCE OF THE TOTAL ENVIRONMENT. 2024; 912: 168816-168816 Nº de citas: 6 [doi:10.1016/j.scitotenv.2023.168816]

Pacheco-Barcia, V; Custodio-Cabello, S; Carrasco-Valero, F; Palka-Kotlowska, M; Mariño-Mendez, A; Carmona-Bayonas, A; Gallego, J; Martín, AJM; Jimenez-Fonseca, P; Cabezon-Gutierrez, L.

Systemic Inflammation Response Index and weight loss as prognostic factors in metastatic pancreatic cancer: A concept study from the PANTHEIA-SEOM trial

World Journal of Gastrointestinal Oncology. 2024; 16(2): Nº de citas: 5 [doi:10.4251/wjgo.v16.i2.386]

Martín, AM; Trujillo-Santos, AJ; Martí, E; Jara-Palomares, L; Montero, RM; Gallardo, E; López-Núñez, JJ; Brozos-Vázquez, E; Robles-Marinas, V; Pérez-Segura, P; Ruíz-Artacho, P.

Improvement of thrombosis management in patients with cancer: a practical consensus document of recommendations for cancer-associated thrombosis patients' healthcare in Spain

CLINICAL & TRANSLATIONAL ONCOLOGY. 2024; 26(6): 1319-1328 [doi:10.1007/s12094-023-03379-z]

Ciruelos, E; García-Sáenz, JA; Gavilá, J; Martín, M; Rodríguez, CA; Rodríguez-Lescure, A.

Safety profile of trastuzumab deruxtecan in advanced breast cancer: Expert opinion on adverse event management

CLINICAL & TRANSLATIONAL ONCOLOGY. 2024; 26(7): 1539-1548 Nº de citas: 7 [doi:10.1007/s12094-024-03383-x]

Morales, MG; Visa, L; Vázquez, EB; Batlle, JF; Shahi, PK; Sáez, BL; Hernández, BLD; Macarulla, T; Sarrió, RG.

Update on the management of older patients with pancreatic adenocarcinoma: a perspective from medical oncology

CLINICAL & TRANSLATIONAL ONCOLOGY. 2024; 26(7): 1570-1583 Nº de citas: 1 [doi:10.1007/s12094-024-03386-8]

Loibl S; André F; Bachelot T; Barrios CH; Bergh J; Burstein HJ; Cardoso MJ; Carey LA; Dawood S; Del Mastro L; Denkert C; Fallenberg EM; Francis PA; Gamal-Eldin H; Gelmon K; Geyer CE; Gnant M; Guarneri V; Gupta S; Kim SB; Krug D; Martin M; Meattini I; Morrow M; Janni W; Paluch-Shimon S; Partridge A; Poortmans P; Pusztai L; Regan MM; Sparano J; Spanic T; Swain S; Tjulandin S; Toi M; Trapani D; Tutt A; Xu B; Curigliano G; Harbeck N.

Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

ANNALS OF ONCOLOGY. 2024; 35(2): 159-182 Nº de citas: 335 [doi:10.1016/j.annonc.2023.11.016]